ProQR Therapeutics N.V. Begins Enrollment for PQ-010-001 Study By: Benzinga via Benzinga June 26, 2015 at 08:10 AM EDT ProQR Therapeutics N.V.(PRQR) says enrollment has started in study PQ-010-001, a global Phase 1b clinical study of QR-010, an ... Read More >> Related Stocks: Proqr Therapeutics